Joanna Clancy
Papers
1
Total Citations
24
H-Index
1
About
Joanna Clancy is a pioneering figure in the development of high-throughput screening technologies for endocrine disruptor research. Her seminal 1999 work, "An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands," established a foundational methodology that has been cited 24 times, reflecting its enduring relevance in toxicology and drug discovery. Clancy’s primary contributions lie in creating robust, scalable assays to detect estrogen receptor ligands, enabling rapid identification of potential environmental and pharmaceutical compounds that interact with hormonal pathways. This innovation has profound implications for public health, allowing researchers to screen thousands of compounds efficiently for endocrine-disrupting activity. Beyond this landmark study, Clancy’s work has advanced the integration of automation and miniaturization in biological screening, setting standards for reproducibility and throughput. Her achievements have been recognized through collaborations with regulatory agencies and academic institutions, where her assays are now standard tools. For students and researchers, Clancy’s legacy demonstrates how a single, well-designed assay can transform a field—bridging chemistry, biology, and environmental science to address critical questions about chemical safety and human health.
Research Focus
Key Achievements
Top Papers
- 1An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands24 citations · 1999